Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1981 Jan;36(1):60–62. doi: 10.1136/thx.36.1.60

Serum immunoreactive trypsin in cystic fibrosis.

P Dandona, M Hodson, J Bell, L Ramdial, I Beldon, J C Batten
PMCID: PMC471443  PMID: 7292384

Abstract

Serum immunoreactive trypsin (IRT) concentrations were measured blind in sera from 33 patients with cystic fibrosis and in 32 age-matched controls. Thirty-two patients had abnormal trypsin concentrations. In 30 of these patients the level of IRT was very low whereas in the other two (the youngest of the group) it was extremely high. All 30 patients with low IRT concentrations had clinical or biochemical evidence of malabsorption. Serum IRT concentration may thus be a useful diagnostic test for cystic fibrosis. In view of the recent observation that neonates with cystic fibrosis consistently have raised IRT concentrations, and the fact that the youngest two patients in our series also had markedly increased IRT, it would appear that the initial elevation of IRT reflects early damage to the pancreas with release of enzyme/zymogen; this is thereafter superseded by a progressive destruction of the pancreas resulting in low IRT concentrations in adults with cystic fibrosis.

Full text

PDF
60

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blomfield J., Dascalu J., van Lennep E. W., Brown J. M. Hypersecretion of zymogen granules in the pathogenesis of cystic fibrosis. Gut. 1973 Jul;14(7):558–565. doi: 10.1136/gut.14.7.558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Conover J. H., Conod E. J., Hirschhorn K. Studies on ciliary dyskinesia factor in cystic fibrosis. IV. Its possible identification as anaphylatoxin (C3a)-IgG complex. Life Sci. 1974 Jan 16;14(2):253–266. doi: 10.1016/0024-3205(74)90055-1. [DOI] [PubMed] [Google Scholar]
  3. Crossley J. R., Elliott R. B., Smith P. A. Dried-blood spot screening for cystic fibrosis in the newborn. Lancet. 1979 Mar 3;1(8114):472–474. doi: 10.1016/s0140-6736(79)90825-0. [DOI] [PubMed] [Google Scholar]
  4. Dandona P., Elias E., Beckett A. G. Serum trypsin concentrations in diabetes mellitus. Br Med J. 1978 Oct 21;2(6145):1125–1125. doi: 10.1136/bmj.2.6145.1125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Elias E., Redshaw M., Wood T. Diagnostic importance of changes in circulating concentrations of immunoreactive trypsin. Lancet. 1977 Jul 9;2(8028):66–68. doi: 10.1016/s0140-6736(77)90066-6. [DOI] [PubMed] [Google Scholar]
  6. Rao G. J., Nadler H. L. Arginine esterase in cystic fibrosis of the pancreas. Pediatr Res. 1974 Jun;8(6):684–686. doi: 10.1203/00006450-197406000-00010. [DOI] [PubMed] [Google Scholar]
  7. Rao G. J., Posner L. A., Nadler H. L. Deficiency of kallikrein activity in plasma of patients with cystic fibrosis. Science. 1972 Aug 18;177(4049):610–611. doi: 10.1126/science.177.4049.610. [DOI] [PubMed] [Google Scholar]
  8. Smalley C. A., Addy D. P., Anderson C. M. Does that child really have cystic fibrosis? Lancet. 1978 Aug 19;2(8086):415–417. doi: 10.1016/s0140-6736(78)91878-0. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES